US health authorities said Tuesday they will import a drug to treat ovarian, bone marrow and AIDS-related skin cancer from India in order to ward off a worrying shortage.
"Lipodox will be imported as an alternative to Doxil," the US Food and Drug Administration said in a statement, noting that a temporary deal has been made with Sun Pharma Global FZE in India to supply US patients with the drug.
"Temporary importation of unapproved foreign drugs is considered in rare cases when there is a
No comments:
Post a Comment